|
AU2019376006A1
(en)
|
2018-11-09 |
2021-06-03 |
Arbutus Biopharma Corporation |
Cationic lipids containing silicon
|
|
CN114901360A
(zh)
|
2019-12-20 |
2022-08-12 |
库瑞瓦格股份公司 |
用于递送核酸的新型脂质纳米颗粒
|
|
US12023376B1
(en)
|
2020-04-17 |
2024-07-02 |
Triad National Security, Llc |
Conserved region T cell vaccines for coronavirus and methods of use
|
|
WO2022011156A1
(en)
*
|
2020-07-10 |
2022-01-13 |
Genevant Sciences Gmbh |
Lipid nanoparticles for delivering therapeutics to lungs
|
|
JP2023535632A
(ja)
|
2020-07-27 |
2023-08-18 |
アンジャリウム バイオサイエンシズ エージー |
Ｄｎａ分子の組成物、その作製方法、及びその使用方法
|
|
CZ310613B6
(cs)
|
2020-09-23 |
2026-01-28 |
Ústav organické chemie a biochemie AV ČR, v. v. i. |
Lipidoidy pro transfekci nukleových kyselin a jejich použití
|
|
EP4228658A4
(en)
|
2020-10-14 |
2025-02-19 |
George Mason Research Foundation, Inc. |
IONIZABLE LIPIDS AND METHODS FOR THE PRODUCTION AND USE THEREOF
|
|
WO2022099003A1
(en)
|
2020-11-06 |
2022-05-12 |
Sanofi |
Lipid nanoparticles for delivering mrna vaccines
|
|
WO2022115645A1
(en)
|
2020-11-25 |
2022-06-02 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids, and related methods of use
|
|
AU2021403156A1
(en)
*
|
2020-12-18 |
2023-07-13 |
Genevant Sciences Gmbh |
Peg lipids and lipid nanoparticles
|
|
EP4308087A4
(en)
*
|
2021-03-17 |
2025-06-18 |
Board of Regents of the University of Nebraska |
LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF
|
|
CN117203340A
(zh)
|
2021-04-16 |
2023-12-08 |
基因泰克公司 |
优化的tlr7配体及其用途
|
|
CZ310443B6
(cs)
|
2021-07-19 |
2025-06-25 |
Ústav organické chemie a biochemie AV ČR, v. v. i. |
Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
|
|
US20240398933A1
(en)
|
2021-09-03 |
2024-12-05 |
CureVac SE |
Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine
|
|
WO2023069948A1
(en)
|
2021-10-18 |
2023-04-27 |
Flagship Pioneering Innovations Vii, Llc |
Dna compositions and related methods
|
|
KR20230061895A
(ko)
*
|
2021-10-29 |
2023-05-09 |
주식회사 아이큐어비앤피 |
지질 나노입자 및 세포 투과성을 갖는 신규 펩타이드의 복합체
|
|
AU2023268051A1
(en)
|
2022-05-13 |
2025-01-02 |
BioNTech SE |
Rna compositions targeting hiv
|
|
CN117203186A
(zh)
*
|
2022-05-13 |
2023-12-08 |
南方科技大学 |
一种含有二硫键的脂质化合物及其组合物
|
|
WO2023230098A1
(en)
|
2022-05-23 |
2023-11-30 |
Logicbio Therapeutics, Inc. |
Gene therapy compositions and methods of use thereof
|
|
JP2025522297A
(ja)
|
2022-05-25 |
2025-07-15 |
ビオンテック エスエー |
サルポックス抗原の送達のためのｒｎａ組成物及び関連する方法
|
|
CA3256897A1
(en)
|
2022-05-25 |
2023-11-30 |
Akagera Medicines, Inc. |
Lipid nanoparticles for the administration of nucleic acids and their methods of use
|
|
JP2025518221A
(ja)
|
2022-05-30 |
2025-06-12 |
ビオンテック・ソシエタス・エウロパエア |
核酸の送達のための複合体
|
|
TWI858802B
(zh)
*
|
2022-07-06 |
2024-10-11 |
南韓商綠十字股份有限公司 |
使用陽離子膽固醇用於核酸遞送的局部遞送的脂質納米顆粒
|
|
AU2023316579A1
(en)
|
2022-07-29 |
2025-02-13 |
Fujifilm Corporation |
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE SIGNAL REGULATORY PROTEIN ALPHA (SIRPα) GENE
|
|
WO2024037577A1
(en)
*
|
2022-08-18 |
2024-02-22 |
Suzhou Abogen Biosciences Co., Ltd. |
Composition of lipid nanoparticles
|
|
WO2024057237A1
(en)
|
2022-09-16 |
2024-03-21 |
Pfizer Inc. |
Lipid nanoparticles
|
|
EP4342460A1
(en)
|
2022-09-21 |
2024-03-27 |
NovoArc GmbH |
Lipid nanoparticle with nucleic acid cargo
|
|
EP4637718A1
(en)
*
|
2022-12-21 |
2025-10-29 |
Suzhou Abogen Biosciences Co., Ltd. |
Lipid nanoparticles comprising sterol-modified phospholipids
|
|
EP4642797A1
(en)
|
2022-12-28 |
2025-11-05 |
BioNTech SE |
Rna compositions targeting hiv
|
|
EP4410316A1
(en)
*
|
2023-02-01 |
2024-08-07 |
4basebio UK Ltd |
Nanoparticles for delivery of nucleic acid cargos
|
|
WO2024167924A2
(en)
*
|
2023-02-06 |
2024-08-15 |
University Of Tennessee Research Foundation |
Multi-functional lipid nanoparticles and uses thereof
|
|
WO2024205499A1
(en)
*
|
2023-03-27 |
2024-10-03 |
Agency For Science, Technology And Research |
A compound for preparing lipid nanoparticles encapsulating an agent, nanoparticle composition comprising said compound and related methods thereof
|
|
WO2024259158A2
(en)
*
|
2023-06-13 |
2024-12-19 |
Cornell University |
Lipid nanoparticles for peptide delivery and methods of making and using the same
|
|
CN121866336A
(zh)
|
2023-08-03 |
2026-04-14 |
百欧恩泰欧洲股份公司 |
靶向hiv的rna组合物
|
|
WO2025027579A2
(en)
|
2023-08-03 |
2025-02-06 |
BioNTech SE |
Rna compositions targeting hiv
|
|
IL326647A
(en)
|
2023-09-01 |
2026-04-01 |
Novoarc Gmbh |
Lipid nanoparticles with a nucleic acid charge and an ionizable lipid
|
|
WO2025124711A1
(en)
|
2023-12-13 |
2025-06-19 |
BioNTech SE |
Glycolipid compositions
|
|
WO2025219570A1
(en)
|
2024-04-17 |
2025-10-23 |
Johannes Kepler Universität Linz |
Composition for inhibiting protein translocation and methods using the same
|
|
WO2025242657A1
(en)
|
2024-05-21 |
2025-11-27 |
Shape Biopharmaceuticals Ag |
Lipopeptide building blocks and aggregates
|
|
GB202408360D0
(en)
|
2024-06-11 |
2024-07-24 |
Cancer Research Tech Ltd |
Tumour sensitisation
|